Rankings
▼
Calendar
MCK Q1 2024 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena
MCK
McKesson Corporation
$115B
Q1 2024 Earnings
Healthcare
Medical - Distribution
Income Statement
Revenue
$74.5B
+10.9% YoY
Gross Profit
$2.8B
3.8% margin
Operating Income
$1.0B
1.4% margin
Net Income
$958M
1.3% margin
EPS (Diluted)
$7.01
QoQ Revenue Growth
+8.1%
Cash Flow
Operating Cash Flow
-$1.1B
Free Cash Flow
-$1.2B
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$64.1B
Total Liabilities
$65.3B
Stockholders' Equity
-$1.6B
Cash & Equivalents
$2.6B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$74.5B
$67.2B
+10.9%
Gross Profit
$2.8B
$2.9B
-4.3%
Operating Income
$1.0B
$1.1B
-2.8%
Net Income
$958M
$768M
+24.7%
Revenue Segments
U.S. Pharmaceutical Segment
$67.2B
90%
International Segment
$3.5B
5%
Medical-Surgical Solutions Segment
$2.6B
4%
Prescription Technology Solutions
$1.2B
2%
← FY 2024
All Quarters
Q2 2024 →